The glossy charts always try to show how some new tech, like genome sequencing, 'outperforms Moore's Law,' but it's mostly hype to make things sound faster.
Moore's Law was about silicon chips, a specific engineering problem, while genome sequencing involves biology and lab automation, entirely different fields.
The real cash flow changes and execution came from biological advances, not a paper about integrated circuits, so the comparison is more an analogy for marketing than a direct influence on the actual work or budget.
It's like saying a new electric car is faster than a horse; sure, but they're not really in the same race with practical constraints.